| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |